| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 4.30B | $ 3.90B | $ 3.66B | $ 3.37B | $ 3.22B |
| Gross Profit | $ 2.66B | $ 2.38B | $ 2.19B | $ 2.00B | $ 1.89B |
| Operating Income | $ 1.36B | $ 1.13B | $ 1.10B | $ 898.76M | $ 932.03M |
| EBITDA | $ 1.47B | $ 1.28B | $ 1.22B | $ 1.01B | $ 1.04B |
| Net Income | $ 1.06B | $ 887.87M | $ 845.04M | $ 679.09M | $ 744.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 180.07M | $ 288.27M | $ 453.93M | $ 112.55M | $ 144.45M |
| Total Assets | $ 3.35B | $ 3.29B | $ 3.26B | $ 2.75B | $ 2.44B |
| Total Debt | $ 1.08B | $ 986.95M | $ 1.07B | $ 1.47B | $ 1.03B |
| Net Debt | $ 897.14M | $ 698.68M | $ 613.42M | $ 1.36B | $ 886.55M |
| Total Liabilities | $ 1.75B | $ 1.70B | $ 1.78B | $ 2.14B | $ 1.75B |
| Stockholders' Equity | $ 1.61B | $ 1.60B | $ 1.48B | $ 608.74M | $ 689.99M |
| Cash Flow | |||||
| Free Cash Flow | $ 1.05B | $ 798.08M | $ 772.88M | $ 394.15M | $ 636.00M |
| Operating Cash Flow | $ 1.18B | $ 929.00M | $ 906.51M | $ 542.98M | $ 755.55M |
| Investing Cash Flow | $ -136.24M | $ -207.06M | $ -125.25M | $ -195.35M | $ -292.97M |
| Financing Cash Flow | $ -1.16B | $ -878.07M | $ -442.00M | $ -370.94M | $ -697.41M |
Idexx Laboratories (CH:IX1)
:IX1
